Montelukast Sodium
NDC Package 42708-042-30

The code 42708-042-30 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Montelukast Sodium, labeled by Qpharma Inc. This is formulated for use and contains as the active substance.

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Qpharma Inc on August 03, 2012. The current certification is valid through June 30, 2021.

Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways.

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42708004230. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.